Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead - - PowerPoint PPT Presentation

drugs and alcohol
SMART_READER_LITE
LIVE PREVIEW

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead - - PowerPoint PPT Presentation

Drugs and Alcohol in Primary Care Steve Brinksman Clinical Lead SMMGP Medical Director Cranstoun Group GP Trends and Issues Traditional drugs Prevalence Alcohol Age Addiction to Medicines Co-morbidities Novel


slide-1
SLIDE 1

Drugs and Alcohol in Primary Care

Steve Brinksman Clinical Lead SMMGP Medical Director Cranstoun Group GP

slide-2
SLIDE 2

Trends and Issues

  • “Traditional” drugs
  • Alcohol
  • Addiction to Medicines
  • Novel Psychoactives
  • Prevalence
  • Age
  • Co-morbidities
  • Recovery v Harm

Reduction

slide-3
SLIDE 3

Drugs ordered by their overall harm scores, showing the separate contributions to the overall scores of harms to users and harm to others. The weights after normalisation (0–100) are shown in the key (cumulative in the sense of the sum of all the normalised weights for all the criteria to users, 46; and for all the criteria to others, 54). CW=cumulative weight. GHB=γ hydroxybutyric acid. LSD=lysergic acid diethylamide.

Drug harms in the UK: a multicriteria decision analysis

The Lancet, Volume 376, Issue 9752, Pages 1558 - 1565, 6 November 2010

doi:10.1016/S0140-6736(10)61462-6

slide-4
SLIDE 4

Estimates suggest over 300,000 problematic heroin & crack users in the UK Over 6 billion £s a year spent on illicit drugs in the UK 70% of acquisitive crime drug related Over a 20 year injecting career, 75% will become infected with hepatitis C Mortality rates between 6-16x higher than general population

slide-5
SLIDE 5

Ageing Populations

slide-6
SLIDE 6
slide-7
SLIDE 7

Age Effects?

slide-8
SLIDE 8

Drug Related Deaths

  • There were 3,744 drug poisoning deaths involving

both legal and illegal drugs registered in England and Wales in 2016, the highest since comparable records began in 1993.

  • Of these, 2,539 (or 69%) were drug misuse deaths

involving illegal drugs only.

  • The mortality rate from drug misuse was the

highest ever recorded, at 65.8 deaths per million population.

slide-9
SLIDE 9

Graph showing deaths, comparing untreated patients with those in Methadone maintenance treatment in the Swedish study (2).

(Reproduced from Gronbladh et al)

slide-10
SLIDE 10

Role of Primary Care

  • Chronic relapsing nature of condition –

patient stays registered whether still using,

  • n OST or abstinent
  • Advantages of primary care treatment,

including continuity and the treatment of associated health problems

  • Familiarity in dealing with complex problems

needing behavioural change

slide-11
SLIDE 11

“Habit is habit, and not to be flung out of the window by any man, but coaxed down-stairs one step at a time.”

Samuel Langhorne Clemens

slide-12
SLIDE 12

Co-morbiditity

  • COPD
  • Ischaemic Heart Disease
  • Hypertension and CKD
  • Liver Disease including Cirrhosis
  • Diabetes
  • Mental Health
  • Poly Drug Use
slide-13
SLIDE 13

Engaging users with treatment programmes has been shown to vastly reduce the cost of drug addiction to society in a number of ways: for every £1 spent on drug treatment, there is a saving of £9.50 to society as a whole

(Department of Health, 2008).

slide-14
SLIDE 14

Reduce barriers to entry High quality medical and psychosocial services Treatment retention Orientation towards social rehabilitation Sufficient duration of treatment Detoxification only of willing, well stabilised patients with established abstinence

slide-15
SLIDE 15

Recovery as a journey

engagement Reintegration Reducing Harm Supported Stability Abstinence Recovery

slide-16
SLIDE 16

Alcohol in the mix

Public Health advises just one glass of wine a day

slide-17
SLIDE 17

Alcohol related deaths

slide-18
SLIDE 18

The numbers – PHE data

FACTS FIGURES LAs 152 Inc + High % 22 Dep % 3.8 Practices 8,261 GPs 33,364 ENGLAND LAs PRACTICE GP Total Population 53,588,218 352,554 6,487 1,606 Adult Population 43,580,873 286,716 5,275 1,306 Dependent drinkers 1,568,911 10,322 190 47 Increasing and Higher Risk 9,849,277 64,798 1,192 295

18 Alcohol interventions in Primary Care 13 Alcohol interventions in Primary Care

slide-19
SLIDE 19
slide-20
SLIDE 20

Chronic Liver Disease

Key drivers for growth in burden and mortality, First 3 all preventable:

  • Alcohol
  • Chronic viral hepatitis B/C
  • Obesity
  • Non-alcoholic fatty liver disease (NAFLD) leading to

non-alcoholic steatohepatitis (NASH)

  • Others – including autoimmune or inherited
  • eg Primary Biliary Cirrhosis (PBC), haemochromatosis
slide-21
SLIDE 21

Prevalence of HCV Infection

Overall, it is estimated that around 214,000 people (0.4%) in the UK are chronically infected with hepatitis C. Despite being a curable infection only 3% of those infected receive treatment each year.

Hepatitis C in the UK 2013. PHE publications gateway number: 2014058 July 2014

slide-22
SLIDE 22

Why Treat Hepatitis C?

Van de Meer et al JAMA 2012

slide-23
SLIDE 23

Primary Care has a key role to play

  • Prevent transmission
  • Increase detection
  • Diagnose infection in people who have the disease
  • Arrange treatment in those with chronic infection with the aim
  • f eradicating the virus, or at least minimising its effects
  • HBV is preventable with an effective vaccine
  • With modern therapy, depending on the genotype of HCV up

to 95% of patients with chronic HCV can be cured

  • Treatment for HCV has been recommended by NICE
slide-24
SLIDE 24

Addiction to Medicines

slide-25
SLIDE 25

Opioid Analgesics

slide-26
SLIDE 26

Opioid deaths mirror prescribing*

  • ONS ‘Deaths Related to Drug Poisoning in England and Wales, 2013’ and
  • ‘Prescription opioid abuse in the UK’, Giraudon I et al., British Journal of Clinical Pharmacology 2013

Addiction to medicines policy November 2014 * Not including illicit opioids

“may signal an emerging problem in the UK similar to the issue that is now well established in the USA.” 50 100 150 200 250 1993 1995 1997 1999 2001 2003 2005 2007 2009 2011 2013 Other opiate Tramadol Dihydrocodeine not from compound Codeine not from compound

slide-27
SLIDE 27

Newer Drugs

Novel Psychoactive Substances, Club Drugs, Legal Highs

slide-28
SLIDE 28

Relevance in Primary Care

  • Secure environments and homeless -SCRAs

[Synthetic Cannabinoid Receptor Agonists]

  • LUTS symptoms in young people-Ketamine
  • Chemsex-GHB,metamfetamine,ketamine
slide-29
SLIDE 29

Public Health v Primary Care

Oh, East is East, and West is West, and never the twain shall meet

Rudyard Kipling

slide-30
SLIDE 30

Commissioning

  • Role of health and Well Being Board
  • Other partners –Third Sector, Police & Crime

Commissioners, Social Services, Housing etc.

  • Links to Secondary Care Services
  • Pathways
slide-31
SLIDE 31

Funding Issues

  • CCG / Public Health split in some areas
  • Competing Priorities
  • Drug and Alcohol treatment not part core

service for GPs

  • However required to work with patients
  • Huge impact on hospital admissions
slide-32
SLIDE 32

Key Points

  • Long term drug use leads to multiple physical

and mental health problems and premature ageing

  • Patterns of drug use change but remain

worryingly high

  • Poly drug use is the usual pattern
  • Primary Care with support from Secondary

Care and the Third Sector can provide effective care and aftercare

slide-33
SLIDE 33